Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Clinical trial NCT05278975 · COMPLETED

Trial details

NCT number: NCT05278975
Sponsor: RS Oncology LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Effusion Malignant Pleural Mesothelioma Mesothelioma Mesotheliomas Pleural Mesothelioma; Lung Pleural Effusion, Malignant

Start date: 2022-03-31
Primary completion: 2025-11-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.